Sex Hormones-Mediated Modulation of Immune Checkpoints in Pregnancy and Recurrent Pregnancy Loss
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031265 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Michał Zych und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology Medical, University of Warsaw, 02-006 Warsaw, Poland. Hauptthemen laut MEDLINE: Abortion, Habitual, Gonadal Steroid Hormones, Immune Checkpoint Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Warsaw, Medical University of Warsaw, Poland, department statutory.
Abstract (Originalsprache)
Recurrent pregnancy loss (RPL) is defined as the loss of two or more pregnancies before the 22nd gestational week and affects 10–15% of clinical pregnancies. Despite extensive diagnostics, over 50% of RPL cases remain unexplained, suggesting an important role for immunological mechanisms. Sex hormones (SH) are key regulators of immune responses during pregnancy; however, their influence on immune checkpoint proteins (ICPs) is poorly understood. This study evaluated the effects of progesterone, β-estradiol, and dihydrotestosterone (DHT) on ICP expression on immune cells, including Treg, NK, NKT, TC, Th, and T cells, collected from pregnant women and patients with unexplained RPL (uRPL). Peripheral blood mononuclear cells from 20 pregnant women and 20 uRPL patients were cultured for 48 h with SH. The expression of the first generation of ICPs—PD-1 and TIM-3—and the second—LAG-3, TIGIT, and VISTA—on T, NK, and NKT cells was analyzed by the flow cytometry method. In pregnant women, SH exerted modest effects, with DHT increasing VISTA and LAG-3 expression, while progesterone and estradiol mainly upregulated LAG-3 and TIM-3 on cytotoxic cells. In contrast, uRPL immune cells showed pronounced SH sensitivity, characterized by increased TIM-3 and VISTA expression and reduced TIGIT expression, particularly after DHT stimulation. In conclusion, SH modulates ICP expression in a cell-specific manner, with stronger effects observed in uRPL patients’ lymphocytes. These findings highlight a potential role for hormonal and ICP-targeted strategies in RPL management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology Medical, University of Warsaw, 02-006 Warsaw, Poland.
- Department of Logic and Cognitive Science, Faculty of Psychology, Adam Mickiewicz University, 61-712 Poznan, Poland.
- Laboratory of Cellular and Genetic Therapies, Medical University of Warsaw, 02-091 Warsaw, Poland.
- Department of Bioinformatics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-091 Warsaw, Poland.
- Department of Gynecology and Gynecological Oncology, Medical Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.
ORCID-Profile: Michał Zych, Marzenna Zakrzewska, Radosław Zagożdżon, Leszek Pączek, Filip Andrzej Dąbrowski, Monika Joanna Kniotek
Förderung
- Medical University of Warsaw
- Medical University of Warsaw, Poland
- department statutory
Zitieren
APA
Zych, M., Roszczyk, A., Zakrzewska, M., Zagożdżon, R., Pączek, L., Dąbrowski, F. A., & Kniotek, M. J. (2026). Sex Hormones-Mediated Modulation of Immune Checkpoints in Pregnancy and Recurrent Pregnancy Loss. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031265
Vancouver
Zych M, Roszczyk A, Zakrzewska M, Zagożdżon R, Pączek L, Dąbrowski FA, et al. Sex Hormones-Mediated Modulation of Immune Checkpoints in Pregnancy and Recurrent Pregnancy Loss. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031265
BibTeX
@article{Zych2026,
author = {Zych, Michał and Roszczyk, Aleksander and Zakrzewska, Marzenna and Zagożdżon, Radosław and Pączek, Leszek and Dąbrowski, Filip Andrzej and Kniotek, Monika Joanna},
title = {Sex Hormones-Mediated Modulation of Immune Checkpoints in Pregnancy and Recurrent Pregnancy Loss},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031265}
}
EUVIMED